Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy and treatment of advanced disease is challenging. Clinical trials with multi-tyrosine kinase inhibitors in the past have yielded disappointing results. Here, we investigated fibroblast growth factor (FGF) receptors and their pathways in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sbiera, Iuliu, Kircher, Stefan, Altieri, Barbara, Lenz, Kerstin, Hantel, Constanze, Fassnacht, Martin, Sbiera, Silviu, Kroiss, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699171/
https://www.ncbi.nlm.nih.gov/pubmed/34956100
http://dx.doi.org/10.3389/fendo.2021.795116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699171/
https://www.ncbi.nlm.nih.gov/pubmed/34956100
http://dx.doi.org/10.3389/fendo.2021.795116

Ejemplares similares